absorb signific headwind fx/tariff behind
strong price power china less certain
china slow pt remain equal-weight
back-half underli ep guid ex-fx tariff demand stabil
critic nomin maintain guidanc
ep growth rais underli ep guid
consid net tariff cost strong price increas
increment fx headwind sinc april new tariff announc mid-juli
could go effect august would repres downsid
guid possibl anoth downsid guidanc
top-lin slowdown organ growth last
year appear appropri given see durabl market condit though
top tough comp less certain stabil long-
term appeal remain unchang see headi territori would
inclin posit stock lower multipl pt remain
caution china continu see suprem high qualiti
asset continu see share gain behind execut howev
macro data continu suggest slowdown key driver china
observ continu deceler proprietari lead indic
index see momentum intact expect notabl slowdown
ms-chex index lead growth quarter continu
deceler private/so fix asset invest china ms
apac capmi june capmi read
end market remain healthi despit isol pocket uncertainti china
better fear in-lin encourag commentari
space settl market share debat china saw momentum
acceler behind china industri level saw benefit
govern stimulu industri remain robust product inspect
growth tough comp normal hsd even despit us facil
transit subsid packag food custom
seen slow larg order tilt toward chemic
pharma food custom see sustain food retail
better expect driven lumpi us project flow lab organ ex-
life scienc tool diagnost unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
biotix remain steadi base busi execut continu
drive growth broader tool
exhibit proprietari global ip index suggest growth normal
select highlight quarter call guidanc goe unchang
despit increment cent headwind fx tariff indic
mtd abil off-set headwind pricing/suppli chain action well
strength underli busi ii price
fifth-straight quarter despit guidanc note price
increas may difficult implement product line impact tariff
competit face headwind iii china acceler
stack environ remain solid though benefit pent-
industri demand expect fade iv europ growth stabl
consid comp adjust bright spot consid
new product flow servic widen moat note new technolog
product introduct process analyt segment includ new oxygen
meter calibr oxygen sensor turbid sensor intend
beer manufactur singl product like move needl
manag call new product signal continu invest
technolog allow maintain competit advantag vs smaller peer
fewer resourc addit highlight servic grew
quarter discuss initi place penetr exist
account increas percentag instal base servic contract
also leverag big data identifi new servic opportun
lower estim increment headwind pt despit strong
quarter rais organ growth estim lower
ebit margin assumpt given fx headwind
increment clariti tariff overal lower ep lower
pt base yield mid estim
deriv base case scenario
bull case ep
bull case ep
robust cyclic recoveri along momentum lab growth food
retail lead sustain hsd top-line growth ebit margin expand
driven effici initi stronger price power multipl
expand ep peak in-lin current level
ep growth
base ep
base ep
price target deriv target fcfi
premium tool peer in-lin histor averag support
dcf incorpor wacc beta outlook incorpor
organ growth driven normal industri environ msd-
hsd lab growth lsd food retail growth margin expand yy
price cost program multipl contract ep in-lin
three-year averag ep growth
bear ep
bear ep
china industri slow lab growth stall tougher comp food retail
declin project time lead lsd top-line growth oper margin
expand given increas spend field turbo less price power
expect multipl contract in-lin ten-year averag
decomposit valuat near-
term long-term growth compon
use price
analysi suggest view sustain
strong sale margin trend appear
factor current stock price limit
excess return versu peer coverag
visibl consist margin
expans growth support high
multipl rel multipl vs tool
 higher long-term
multipl appropri given above-p
comparison measur
confound low mix intang
exposur china industri
highest coverag introduc greater
element cyclic uncertainti
spinnak enabl target sale
market lead sustain market
increas focu servic attach rate
growth spur revenu profit gain
strong manag track record
risk achiev price
margin expans weigh sale
recoveri china slower expect
local currenc biotix balanc grew quit well analyt instrument pipett good growth yr stack
process analyt excel growth
local currenc industri asia strong eu strong america growth pi modestli
local currenc given project activ us europ modestli asia/row
lc growth lab industri solid pi bc comp retail strong project
lc growth industri strong lab good retail
lc growth excel lab good industri retail modestli
china grew strong lab growth industri grew
exhibit pmi remain across geographi us
acceler straight month europ deceler
peak march
morgan stanley research ism
note morgan stanley short cycl growth index geograph weight averag short cycl
industri growth indic index track individu industri data point span region
car sale machin tool demand bear demand machineri sale
guidanc
biotix acq
biotix acq
exhibit chang forecast
guidanc
organ
biotix
organ
biotix
sale
sale
sale
sale
sale
sale
million except ep
valuat risk
exhibit capit effici support higher multipl
thomson reuter morgan stanley research
bloomberg thomson reuter morgan stanley research
thomson reuter morgan stanley research
exhibit rel price-to-earnings vs
thomson reuter morgan stanley research
price target impli yield mid
estim support dcf analysi incorpor wacc beta
outlook incorpor organ growth organ ebit margin
expans impli multipl ep target price-to-earnings also within rang
impli roe-co analysi
upsid risk price target includ sustain macro recoveri drive hsd industri
growth continu msd-hsd lab growth better expect margin expans
robust cost program downsid risk includ slowdown cyclic indic
slower expect margin expans weak lab/food retail growth
earn tax
provis tax
revenu product area
sale
sale
sale
total revenu product area
